Clinical trial
Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema
NCT00097695 · Shire, Industry · Completed
Key facts
| NCT number | NCT00097695 |
|---|---|
| Title | Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema |
| Official title | Randomized, Double Blind, Placebo-Controlled, Multicenter Study of a Subcutaneous Formulation of Icatibant for the Treatment of Hereditary Angioedema |
| Lead sponsor | Shire, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Angioedema |
| Intervention type | Drug |
| Interventions | Icatibant, Placebo |
| Enrollment | 84 |
| Start date | Dec 28, 2004 |
| Primary completion | Jul 17, 2006 |
| Completion | Jul 17, 2006 |
| First posted | Nov 29, 2004 |
| Last update posted | Jun 9, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: